S
Live / Allowed — Published for opposition (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99154994
- Mark type
- Word mark
- Filed
- 25 Apr 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Hillary E. Maynard
Goods and services
- Class 005 — Pharmaceuticals: Implantable drug delivery devices with integrated pharmaceutical preparations for use in conjunction with intraocular lenses and intraocular implant platforms for receiving pharmaceutical preparations to treat eye conditions
- Class 010 — Medical apparatus: Intraocular implants, namely, intraocular lenses and intraocular implant platforms for receiving pharmaceutical preparations; drug delivery devices sold empty for use in conjunction with intraocular lenses and lens stability rings, namely, an acrylic intraocular lens platform equipped for receiving pads; Intraocular implants being lenses; drug delivery devices sold empty for use in conjunction with intraocular implants, namely, an acrylic intraocular lens platform equipped for receiving pads
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, analysis and design of products and technology in the fields of ophthalmic-related health conditions and short-term, intermittent and/or sustained intraocular drug delivery; Product development of technology for the treatment, reducing onset of, and/or prevention of ophthalmic-related health conditions; Research and development services relating to technology for treatment, reducing onset of, and/or prevention of ophthalmic-related health conditions
- Class 044 — Medical, beauty and agricultural services: Providing medical and scientific information and analysis in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof; Providing medical and scientific research information in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof
Owner
- SpyGlass Pharma, Inc., Aliso Viejo, CA, US
- SpyGlass Pharma, Inc., Aliso Viejo, CA, US
Prosecution history
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Sept 2025 — NON-FINAL ACTION E-MAILED
- 18 Sept 2025 — NON-FINAL ACTION WRITTEN
- 16 Sept 2025 — ASSIGNED TO EXAMINER
- 02 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Apr 2025 — NEW APPLICATION ENTERED